Functional Differences Between Wild-Type and Mutant-Type BRCA1-associated Protein 1 Tumor Suppressor Against Malignant Mesothelioma Cells

Cancer Science - United States
doi 10.1111/cas.12698
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

LATS2 Is a Tumor Suppressor Gene of Malignant Mesothelioma

Cancer Research
Cancer ResearchOncology
2011English

Structural Differences Between Wild-Type and Double Mutant EGFR Modulated by Third-Generation Kinase Inhibitors

Journal of the American Chemical Society
BiochemistryColloidCatalysisChemistrySurface Chemistry
2015English

Table 2: Altered Protein Expression Between B. Pseudomallei Wild-Type K96243 and the SDO Mutant.

English

Susceptibility to Radiation Induced Apoptosis and Senescence in P53 Wild Type and P53 Mutant Breast Tumor Cells

2006English

Differences in the Risk Factors Associated With Diabetic Retinopathy Between Type 1 and Type 2 Diabetes Mellitus

Endocrine Abstracts
2016English

Degradation of Overexpressed Wild-Type and Mutant Uricase Proteins in Cultured Cells

Journal of Histochemistry and Cytochemistry
AnatomyHistology
1999English

Radioimmunotargeting of Malignant Glioma by Monoclonal Antibody D2C7 Reactive Against Both Wild-Type and Variant III Mutant Epidermal Growth Factor Receptors

Nuclear Medicine and Biology
Cancer ResearchNuclear MedicineRadiologyMolecular MedicineImaging
2012English

The Human Tumor Suppressor ARF Interacts With Spinophilin/Neurabin II, a Type 1 Protein-Phosphatase-Binding Protein

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2001English

A Farnesyl-Protein Transferase Inhibitor Induces P21 Expression and G1Block in P53 Wild Type Tumor Cells

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1998English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy